PhD student at the Danish Centre for Particle Therapy. Currently working on dosimetry for UHDR beams.

I trained as a Therapeutic Radiographer at Glasgow Caledonian University in 2011 and commenced working at the Edinburgh Cancer Centre in 2014. In 2016, I joined The Christie NHS Foundation Trust in Manchester, where I worked as a Senior Radiographer in the photon department in pre-treatment and treatment. In 2018, I started my role as a Proton Senior Radiographer at The Christie proton centre, prior to the centre being operational. This enabled me to acquire experience such as ProBeam applications training, protocol development and end to end testing. I have experience working in radiotherapy governance, including managing public enquiries and ensuring key performance indicators are met. I have vast experience in proton pre-treatment, including clinical skills, mould room, CT and MR-Sim and I am often involved in proton education and development through The Christie Summer School and Proton School teaching. I have a strong passion for research and development; I am currently completing my MSc in radiotherapy and oncology, focusing my dissertation on proton immobilisation. I look forward to meeting you at the FRPT 2022 conference.

Prof. Karen Kirkby leads the Manchester Proton Therapy research bringing together the research effort at the University of Manchester and The Christie NHS Foundation Trust. She has published over 200 peer reviewed papers including articles in Nature and written for popular science magazines and newspapers. Her work can be seen at Science Museum’s Cancer Revolution exhibition and is featured in the University of Manchester’s Research Impact Showcase https://www.manchester.ac.uk/research/impact/showcase/proton-beam-therapy-centres/ Karen’s research group (Precise) now numbers over 30 people and has built a dedicated proton therapy and FLASH research facility in the NHS Proton Therapy Centre at The Christie.

Final-year PhD student in Medical Physics at Lund University. My research focus is to prepare the electron beam of our modified Elekta linear accelerator for clinical FLASH trials. The projects cover dosimetric and technical developments to allow for safe and accurate delivery of ultra-high dose rates, as well as the treatment of canine cancer patients to investigate the clinical benefit of FLASH.

Dr. Koumenis received a B.S degree in Pharmacy from the Aristotle University of Thessaloniki, Greece, a Ph.D. degree in Biochemistry from the University of Houston, TX and postdoctoral training in Radiation and Tumor Biology at Stanford University. He was appointed Assistant Professor at Wake Forest University School of Medicine in 1999 and in 2006 he moved to the University of Pennsylvania School in Philadelphia, where he is currently the Richard Chamberlain Endowed Professor and Vice-Chair for Research, in the Department of Radiation Oncology. He also serves as the Associate Director for Translational Research of the Abramson Comprehensive Cancer Center at the UPenn. His research interests include the study of the role of the tumor microenvironment on tumor progression, metastasis and resistance to therapy. He and his group are also interested in the development of physiological models of normal tissue damage and the development of novel radiation technologies and modalities including FLASH radiotherapy. He is currently the Principal Investigator or co-PI on multiple research and training grants from the National Institutes of Health and has published over 120 manuscripts in high-impact journals. He currently serves as a standing member on NIH grant review committees and is a member of the steering committee of the Radiation and Medicine Working Group of the American Association for Cancer Research.

Accelerator physicist working at the HZB cyclotron facility that treats eye-tumors and performs proton FLASH irradiation studies with 70 MeV protons, cm-wide PTV and SOBP with 1 mm distal fall-off, beyond 100 Gy/s. Interested in establishing collaborations for further FLASH studies with protons and helium ions (alpha particles), as well as spatially fractionated mini-beams.

After having completed her PhD at PSI on the topic of motion management for proton therapy, Miriam Krieger joined the Flash team at Varian as a research scientist.

Physicist by training; 12+ year experience in semi-conductor lithography and metrology; joined Varian 9 years ago as part of Halcyon transitioning to head up the physics team for all linac systems; joined the FLASH program in 2019; she heads up R&D for electron and proton Flash